Healthcare Provider ChallengesManagement noted that it had underappreciated how overwhelmed by patient volumes practices would be during these peak weeks, which makes doctors less willing to prescribe a new treatment.
Prescription TrendsEnding the GoodRx program has been a headwind for weekly script numbers that have underwhelmed investors in recent weeks; however, this should have minimal impact on revenue.
Stock PerformanceThe weakness in shares of ARS in recent weeks, down over 40% since its highs in July, is considered unwarranted despite facing some headwinds.